News & Updates

Explore how continuous manufacturing strategies can support more scalable, efficient, and cost-effective mAb production. Download this free whitepaper for insights into process integration, regulatory considerations, and long-term biologics manufacturing success.

Early-onset cancers are rising among adults 18–49, reshaping how patients are diagnosed, supported, and engaged. This report examines key trends, gaps in care, and how data and digital strategies are evolving to meet new expectations. Download the report to learn more.

As healthcare professionals increasingly turn to AI tools to seek information, traditional “share of voice” metrics are no longer enough. Today, AI platforms are often answering HCP questions before a brand ever has the opportunity to engage directly, shifting the industry from a push-based communication model to a new “pull” model driven by independent discovery and personalized answers.

To compete in this evolving landscape, commercial teams must rethink how they approach targeting, media, content, and customer engagement. Success will depend on improving visibility across emerging AI-powered channels while equipping field teams with deeper intelligence and real-time insights that enable more relevant, contextual, and personalized interactions with customers.

Key Discussion Points:

• Understanding the shift from “share of voice” to “share of answer”
• Building optichannel engagement strategies for AI-driven customer journeys
• Increasing brand visibility across emerging AI-powered discovery channels
• Leveraging real-time insights and contextual intelligence to personalize engagement
• Enabling field teams to deliver more relevant, data-driven customer interactions
• Rethinking measurement and engagement metrics in the AI era

How can timely, precise lab data improve decision-making across the medicine lifecycle? Download this whitepaper to explore how de-identified laboratory data supports clinical development, commercial strategy, patient insights, and post-market evaluation.

As TIDES programs advance toward commercialization, manufacturing readiness is becoming increasingly important. Download this free whitepaper to explore strategies for scaling peptide and oligonucleotide manufacturing, strengthening supply continuity, accelerating CMC execution, and preparing for evolving industry demands.

AI is rapidly moving from experimentation to real-world application in early drug discovery. But where does it truly add value for CROs and what continues to limit broader adoption?

Join us for this valuable webinar to explore how AI is being applied across early discovery, from target and molecule prioritization to experimental planning and iterative learning across Design–Make–Test–Analyze (DMTA) cycles. The discussion will examine where AI is demonstrating measurable scientific value, how it complements expert judgment, and the practical challenges organizations face when integrating AI into discovery workflows.

Drawing on hands-on experience across multiple discovery environments, we’ll highlight operational and organizational considerations relevant to CROs, including data fragmentation, governance, workflow integration, and change management. You’ll learn about:

• Where AI is showing practical value across early discovery workflows
• How AI can support target identification, molecule prioritization, and DMTA cycles
• Key barriers impacting adoption and workflow integration
• Why scientific oversight remains critical to effective AI implementation
• Considerations for embedding AI into day-to-day discovery environments

Don’t miss key insights on how to approach AI adoption in early discovery and what it takes to integrate AI more effectively into scientific workflows. Register today!

Exploring Precision Logistics as a Competitive Advantage for Nuclear Medicine.

In 2026, radiopharmaceuticals reached a critical inflection point, with a market valuation exceeding $8 billion driven by a surge in complex alpha-emitters and theranostic platforms. As the field advances, scientific innovation alone is no longer enough to ensure commercial success. Logistics, supply chain precision, and delivery execution are becoming equally critical to scaling access and supporting global commercialization.

Join us for this webinar to explore how to move beyond traditional transport models to embrace AI-driven systems and automated just-in-time networks. Hear experts analyze how to mitigate the risks of short half-life decay and navigate evolving regulatory frameworks to ensure global patient access.

You'll learn about:

• The 2026 Radiopharmaceutical Landscape
• Optimizing Logistics for Class 7 Shipments
• Digital Transformations in Supply Chains
• Trends and the Future of Nuclear Medicine